Africa’s path to pharmaceutical independence: a matter of survival

The overwhelming majority of African nations continue to rely heavily on imported medicines to meet the healthcare needs of their populations. In this analysis, Dr. Arnaud Kaboré, a pharmacist and engineer, outlines a strategic roadmap for public leaders to achieve pharmaceutical sovereignty for Africa by 2045.

From dependence to vulnerability: the hidden costs of reliance

Despite progress, fewer than five African countries operate pharmaceutical manufacturing units capable of exporting beyond their regional borders. This persistent gap forces the continent to import 94% of its medicines, with an annual expenditure exceeding $18 billion—a figure projected to surpass $30 billion by 2030. Beyond the economic strain, this dependency exposes Africa to structural vulnerabilities that threaten healthcare security.

Institutional reports reveal that over 70% of public health facilities across Africa experience critical stockouts at least once per quarter. Can a continent home to 1.4 billion people afford to leave its healthcare entirely at the mercy of industrial, logistical, and geopolitical decisions made outside its borders? The Covid-19 pandemic laid bare the consequences: chronic shortages of essential drugs like amoxicillin, insulin, and anesthetics, skyrocketing prices during shortages, and stalled public health programs due to unavailability of cutting-edge treatments such as cancer therapies and advanced pharmaceuticals.

Yet Africa possesses undeniable assets that could reshape its pharmaceutical landscape:

• A rapidly expanding market: The African pharmaceutical sector is projected to exceed $70 billion by 2030.
• Unmatched biological resources: Over 5,400 medicinal plants have been documented, some already integrated into recognized therapeutic protocols.
• Regulatory momentum: The African Medicines Agency (AMA), now ratified by 27 countries, is harmonizing standards across the continent.
• Political will in action: Nations like Burkina Faso, Rwanda, Egypt, Morocco, Senegal, and South Africa have launched ambitious local production initiatives to reduce reliance on imports.

Redefining Africa’s healthcare future: building a resilient pharmaceutical industry

A critical misstep has been the attempt to replicate the models of international